StockData

BillionToOne vs Grail

BLLN and GRAL side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BLLN and GRAL compare

BillionToOne and Grail are about the same size, with market caps of $4.6B and $4.7B.

BillionToOne grew revenue faster over the last twelve months (71.9% versus 23.1% for Grail).

BillionToOne keeps more of each dollar of sales as profit, with a net margin of 11.3% compared with −237% at Grail.

BillionToOne scores higher on the StockData Score (11 against 10 for Grail), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBLLNGRAL
Size and price
Market cap$4.6B$4.7B
Share price$97.50$105.88
Change, 1 year8.3%33.0%
Beta (5Y)0.382.06
Employees713910
StockData Score
Total score11 (better)10
Valuation score01 (better)
Growth score3 (better)2
Performance score2 (better)1
Health score66
Dividend score00
Valuation
P/S10.5× (better)28.6×
P/B8.1×1.9× (better)
EV/EBITDA77.8×–
P/FCF136×–
FCF yield0.74% (better)−6.3%
Growth
Revenue growth (TTM)71.9% (better)23.1%
Profitability
Gross margin71.4%–
Operating margin10.2% (better)−338%
Net margin11.3% (better)−237%
FCF margin7.8% (better)−179%
Return on equity30.2% (better)−16.1%
Return on invested capital–−26.0%
Financial health
Debt / equity0.000.00
Interest coverage1655×–
Current ratio11.25 (better)10.95
Altman Z-score15.56 (better)4.06
Piotroski F-score8 (better)5
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions32.4%87.6%
Held by insiders55.7%11.0%
Insider net buying, 12 months−$58.5M−$38.3M (better)
Short interest, % of float14.2%20.1%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.